A New-Onset Rash in the Setting of Rifaximin Treatment for Hepatic Encephalopathy

We present one of the first cases in the literature to describe an association between Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and rifaximin treatment in a patient with a recent diagnosis of alcoholic hepatitis, stage 2 hepatic encephalopathy, and no known existing allergies. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Fritz, Cassandra D.L., Adebajo, Corlan, Aronsohn, Andrew, Jensen, Donald M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Gastroenterology 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435342/
https://www.ncbi.nlm.nih.gov/pubmed/26157902
http://dx.doi.org/10.14309/crj.2014.79
_version_ 1782371904166821888
author Fritz, Cassandra D.L.
Adebajo, Corlan
Aronsohn, Andrew
Jensen, Donald M.
author_facet Fritz, Cassandra D.L.
Adebajo, Corlan
Aronsohn, Andrew
Jensen, Donald M.
author_sort Fritz, Cassandra D.L.
collection PubMed
description We present one of the first cases in the literature to describe an association between Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and rifaximin treatment in a patient with a recent diagnosis of alcoholic hepatitis, stage 2 hepatic encephalopathy, and no known existing allergies. Although SJS/TEN may be a rare reaction with rifaximin, it should be an important clinical consideration.
format Online
Article
Text
id pubmed-4435342
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American College of Gastroenterology
record_format MEDLINE/PubMed
spelling pubmed-44353422015-07-08 A New-Onset Rash in the Setting of Rifaximin Treatment for Hepatic Encephalopathy Fritz, Cassandra D.L. Adebajo, Corlan Aronsohn, Andrew Jensen, Donald M. ACG Case Rep J Case Report We present one of the first cases in the literature to describe an association between Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and rifaximin treatment in a patient with a recent diagnosis of alcoholic hepatitis, stage 2 hepatic encephalopathy, and no known existing allergies. Although SJS/TEN may be a rare reaction with rifaximin, it should be an important clinical consideration. American College of Gastroenterology 2014-10-10 /pmc/articles/PMC4435342/ /pubmed/26157902 http://dx.doi.org/10.14309/crj.2014.79 Text en Copyright © Fritz et al. This is an open-access article. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Case Report
Fritz, Cassandra D.L.
Adebajo, Corlan
Aronsohn, Andrew
Jensen, Donald M.
A New-Onset Rash in the Setting of Rifaximin Treatment for Hepatic Encephalopathy
title A New-Onset Rash in the Setting of Rifaximin Treatment for Hepatic Encephalopathy
title_full A New-Onset Rash in the Setting of Rifaximin Treatment for Hepatic Encephalopathy
title_fullStr A New-Onset Rash in the Setting of Rifaximin Treatment for Hepatic Encephalopathy
title_full_unstemmed A New-Onset Rash in the Setting of Rifaximin Treatment for Hepatic Encephalopathy
title_short A New-Onset Rash in the Setting of Rifaximin Treatment for Hepatic Encephalopathy
title_sort new-onset rash in the setting of rifaximin treatment for hepatic encephalopathy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435342/
https://www.ncbi.nlm.nih.gov/pubmed/26157902
http://dx.doi.org/10.14309/crj.2014.79
work_keys_str_mv AT fritzcassandradl anewonsetrashinthesettingofrifaximintreatmentforhepaticencephalopathy
AT adebajocorlan anewonsetrashinthesettingofrifaximintreatmentforhepaticencephalopathy
AT aronsohnandrew anewonsetrashinthesettingofrifaximintreatmentforhepaticencephalopathy
AT jensendonaldm anewonsetrashinthesettingofrifaximintreatmentforhepaticencephalopathy
AT fritzcassandradl newonsetrashinthesettingofrifaximintreatmentforhepaticencephalopathy
AT adebajocorlan newonsetrashinthesettingofrifaximintreatmentforhepaticencephalopathy
AT aronsohnandrew newonsetrashinthesettingofrifaximintreatmentforhepaticencephalopathy
AT jensendonaldm newonsetrashinthesettingofrifaximintreatmentforhepaticencephalopathy

Ejemplares similares